UPDATE: Power restored in New Bern after thousands lose service
The above video is our WITN+ livestream and may not reflect the content in this story. NEW BERN,…
Arrest made in 2024 New Bern murder
The above video is our WITN+ livestream and may not reflect the content in this story. NEW BERN,…
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease
Pluvicto now approved across PSMA+ metastatic prostate cancer, nearly doubling eligible patient population PSMAddition updated results show Pluvicto…
WFP Geneva Palais Briefing Note: WFP warns El Obeid is becoming the new epicentre of Sudan’s displacement and hunger crisis
This is a summary of what was said by Abdallah Aldawart, WFP’s Country Director for Sudan (speaking from…
Brandon Capital Announces Agreement for Novartis to Acquire Portfolio Company Myricx Bio to Advance New Class of Cancer Therapeutics
MELBOURNE, Australia, July 06, 2026 (GLOBE NEWSWIRE) — Brandon Capital, Australasia’s leading life sciences venture capital firm, today…
Rabid raccoon found in New Bern
The above video is our WITN+ livestream and may not reflect the content in this story. NEW BERN,…
IPD and ABB Help Power Sustainable Operations at New Sydney Fish Market
SYDNEY, June 22, 2026 /PRNewswire/ — IPD, in partnership with ABB Australia and Equilibrium Climatech Joint Venture (ECJV), has…
Drug investigation in New Bern lands man in jail on several charges
The above video is our WITN+ livestream and may not reflect the content in this story. CRAVEN COUNTY,…
Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients
Clinically meaningful, statistically significant efficacy achieved in primary and all secondary endpoints, including reduced steroid use; safety consistent…
FDA accepts New Drug Application for Roche’s giredestrant in ER-positive early-stage breast cancer, the first and only oral SERD with positive phase III results in the curative setting
Filing acceptance, under priority review, based on phase III data showing giredestrant reduced the risk of invasive disease…
New Novartis data at ERA 2026 advance scientific understanding of kidney disease and reinforce portfolio strength
Late-breaking Phase III IgAN data for Vanrafia ALIGN and Fabhalta APPLAUSE-IgAN studies to be presented124-week Phase I/II zigakibart…
Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA
Pluvicto®PSMAddition oral presentation to highlight efficacy outcomes by disease volume and de novo/recurrent metastatic hormone-sensitive prostate cancer Kisqali®…